PFS Investments’s Bristol-Myers Squibb BMY Stock Holding History

PFS Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$52.4M	Buy	819,878 +38,938	+5%	+$2.61M	0.86%	24
2023 Q1	$55.2M	Buy	780,940 +197,024	+34%	+$13.9M	0.96%	20
2022 Q4	$42M	Sell	583,916 -30,758	-5%	-$2.32M	0.78%	28
2022 Q3	$43.7M	Buy	614,674 +88,164	+17%	+$6.4M	0.79%	16
2022 Q2	$40.5M	Buy	526,510 +94,532	+22%	+$7.2M	0.81%	21
2022 Q1	$31.5M	Sell	431,978 -23,262	-5%	-$1.56M	0.6%	47
2021 Q4	$28.4M	Buy	455,240 +141,589	+45%	+$8.31M	0.55%	55
2021 Q3	$18.6M	Buy	313,651 +30,312	+11%	+$2M	0.39%	69
2021 Q2	$19M	Buy	283,339 +72,061	+34%	+$4.7M	0.43%	63
2021 Q1	$13.3M	Buy	211,278 +16,359	+8%	+$1.02M	0.34%	81
2020 Q4	$12.7M	Buy	194,919 +18,279	+10%	+$1.12M	0.36%	75
2020 Q3	$10.7M	Buy	176,640 +22,709	+15%	+$1.37M	0.35%	70
2020 Q2	$9.05M	Buy	153,931 +24,105	+19%	+$1.44M	0.33%	70
2020 Q1	$7.24M	Buy	129,826 +29,851	+30%	+$1.82M	0.31%	56
2019 Q4	$6.42M	Buy	99,975 +24,389	+32%	+$1.4M	0.25%	79
2019 Q3	$3.83M	Buy	75,586 +22,807	+43%	+$1.07M	0.16%	90
2019 Q2	$2.42M	Buy	52,779 +29,718	+129%	+$1.38M	0.11%	84
2019 Q1	$1.1M	Buy	+23,061	New	+$1.15M	0.05%	84

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

PFS Investments's BMY Position: Q2 2023 in Review

PFS Investments increased its Bristol-Myers Squibb (BMY) stake by 5% in Q2 2023, buying an estimated $2.61M and bringing the position to 819,878 shares worth $52.4M. The position accounts for 0.86% of the portfolio, ranked #24.

PFS Investments first reported a position in BMY in Q1 2019 and has held it in 18 quarters since. The position peaked at $55.2M in Q1 2023. 2,482 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

PFS Investments held 819,878 shares of Bristol-Myers Squibb worth $52.4M as of Q2 2023.
PFS Investments bought 38,938 Bristol-Myers Squibb shares in Q2 2023, an estimated $2.61M.
Bristol-Myers Squibb made up 0.86% of PFS Investments's portfolio in Q2 2023, its #24 holding.
PFS Investments first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 18 quarters since.
PFS Investments's Bristol-Myers Squibb position peaked at $55.2M in Q1 2023.
2,482 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.